CD26/DPP4 is widely expressed in various cell types in lung tissues, such as Type I and II alveolar cells, alveolar macrophages, and vascular endothelial cells, and has recently been suggested as a therapeutic target in lung diseases [19,23,24,25,27,28]. Here, DPP4 is linked to lung disorder.